1. P48 Telaprevir substantially improved SVR rates across all IL28B genotypes in the advance trial. (6th September 2011) Authors: Dusheiko, G M; Jacobson, I M; Catlett, I; George, S; Seepersaud, S; Ramachandran, R; Sussky, K; Kauffman, R S; Botfield, M Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗